Literature DB >> 1854633

The long term prognostic significance of oestrogen receptor analysis in early carcinoma of the breast.

J Winstanley1, T Cooke, W D George, G Murray, S Holt, R Croton, K Griffiths, R Nicholson.   

Abstract

The long term prognostic significance of oestrogen receptors was assessed in a prospective study of 767 patients presenting between the years 1975 and 1981 with stage 1 and 2 breast cancer treated by mastectomy with either full axillary dissection or nodal sampling. Oestrogen receptor binding was determined by a dextran coated charcoal method and median follow up was 11 years. Oestrogen receptors were present in 396 (54%) of tumours. Absence of oestrogen receptors was associated with tumours of high histological grade, but there was no relationship between nodal status or tumour size. Oestrogen receptor status did not predict survival for the group as a whole or when stratified by nodal status. In multivariate analysis both nodal status and tumour size were powerful independent prognostic factors, but oestrogen receptors failed to achieve statistical significance.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1854633      PMCID: PMC1977324          DOI: 10.1038/bjc.1991.249

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  28 in total

Review 1.  Who needs steroid receptor assays?

Authors:  D M Barnes; I S Fentiman; R R Millis; R D Rubens
Journal:  Lancet       Date:  1989-05-20       Impact factor: 79.321

2.  Relation between estrogen receptor concentration and clinical and histological factors: their relative prognostic importance after radical mastectomy for primary breast cancer.

Authors:  G Andry; S Suciu; D Pratola; R Sylvester; G Leclercq; P M da Costa; N Legros; M Andry-t'Hooft; A Verhest; W Mattheiem
Journal:  Eur J Cancer Clin Oncol       Date:  1989-02

3.  Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer.

Authors:  W A Knight; R B Livingston; E J Gregory; W L McGuire
Journal:  Cancer Res       Date:  1977-12       Impact factor: 12.701

4.  Prognostic value of estrogen and progesterone receptors in primary infiltrating ductal breast cancer. A sequential multivariate analysis of 1262 patients.

Authors:  F Spyratos; K Hacene; M Tubiana-Hulin; C Pallud; M Brunet
Journal:  Eur J Cancer Clin Oncol       Date:  1989-08

5.  Survival with breast cancer: the importance of estrogen receptor quantity.

Authors:  L L Shek; W Godolphin
Journal:  Eur J Cancer Clin Oncol       Date:  1989-02

6.  Activated oestrogen receptor in human breast cancer: clinical and biochemical correlates.

Authors:  J O White; M J Herschman; G Parmar; K A Philipson; M G Elder; N A Habib; C B Wood
Journal:  Br J Surg       Date:  1987-07       Impact factor: 6.939

7.  Prediction of endocrine response in breast cancer by immunocytochemical detection of oestrogen receptor in fine-needle aspirates.

Authors:  R C Coombes; T J Powles; U Berger; P Wilson; R A McClelland; J C Gazet; P A Trott; H T Ford
Journal:  Lancet       Date:  1987-09-26       Impact factor: 79.321

8.  Prognostic significance of estrogen receptor status in breast cancer in relation to tumor stage, axillary node metastasis, and histopathologic grading.

Authors:  F F Parl; B P Schmidt; W D Dupont; R K Wagner
Journal:  Cancer       Date:  1984-11-15       Impact factor: 6.860

9.  Histochemical detection of oestrogen receptors in breast carcinoma: a successful technique.

Authors:  R A Hawkins; K Sangster; A Krajewski
Journal:  Br J Cancer       Date:  1986-03       Impact factor: 7.640

10.  Oestrogen and progesterone receptors and disease-free interval in primary breast cancer.

Authors:  A Alanko; E Heinonen; T M Scheinin; E M Tolppanen; R Vihko
Journal:  Br J Cancer       Date:  1984-11       Impact factor: 7.640

View more
  11 in total

1.  Multicentric Breast Carcinoma: Evaluation of Clinicopathological and Immunohistochemical Characteristics.

Authors: 
Journal:  Breast Cancer       Date:  1996-12-20       Impact factor: 4.239

2.  Quantitative histopathology in lymph node-negative breast cancer. Prognostic significance of mitotic counts.

Authors:  M Ladekarl; V Jensen
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 3.  Toward checkmate: biology and breast cancer therapy for the new millennium.

Authors:  K D Miller; G W Sledge
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

4.  Prognostic role of oestrogen and progesterone receptors in patients with breast cancer: relation to age and lymph node status.

Authors:  K Collett; F Hartveit; R Skjaerven; B O Maehle
Journal:  J Clin Pathol       Date:  1996-11       Impact factor: 3.411

5.  Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility.

Authors:  T I Andersen; K R Heimdal; M Skrede; K Tveit; K Berg; A L Børresen
Journal:  Hum Genet       Date:  1994-12       Impact factor: 4.132

6.  Hormone receptor status in breast cancer and its relation to age and other prognostic factors.

Authors:  Ali Pourzand; M Bassir A Fakhree; Shahryar Hashemzadeh; Monireh Halimi; Amir Daryani
Journal:  Breast Cancer (Auckl)       Date:  2011-05-18

7.  Role of p-glycoprotein expression in predicting response to neoadjuvant chemotherapy in breast cancer--a prospective clinical study.

Authors:  Jai Parakash Singh; Mahesh K Mittal; Sunita Saxena; Anju Bansal; Ashima Bhatia; Pranjal Kulshreshtha
Journal:  World J Surg Oncol       Date:  2005-09-14       Impact factor: 2.754

8.  Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis.

Authors:  L Hilakivi-Clarke; I Onojafe; M Raygada; E Cho; T Skaar; I Russo; R Clarke
Journal:  Br J Cancer       Date:  1999-08       Impact factor: 7.640

9.  Prognostic significance of cathepsin-D in patients with breast cancer.

Authors:  J H Winstanley; S J Leinster; T G Cooke; B R Westley; A M Platt-Higgins; P S Rudland
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640

10.  Higher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistance.

Authors:  L-Y Luo; E P Diamandis; M P Look; A P Soosaipillai; J A Foekens
Journal:  Br J Cancer       Date:  2002-06-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.